Literature DB >> 26202064

Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets.

H Gregg Claycamp1,2, Ravikanth Kona3, Raafat Fahmy2, Stephen W Hoag4.   

Abstract

Qualitative risk assessment methods are often used as the first step to determining design space boundaries; however, quantitative assessments of risk with respect to the design space, i.e., calculating the probability of failure for a given severity, are needed to fully characterize design space boundaries. Quantitative risk assessment methods in design and operational spaces are a significant aid to evaluating proposed design space boundaries. The goal of this paper is to demonstrate a relatively simple strategy for design space definition using a simplified Bayesian Monte Carlo simulation. This paper builds on a previous paper that used failure mode and effects analysis (FMEA) qualitative risk assessment and Plackett-Burman design of experiments to identity the critical quality attributes. The results show that the sequential use of qualitative and quantitative risk assessments can focus the design of experiments on a reduced set of critical material and process parameters that determine a robust design space under conditions of limited laboratory experimentation. This approach provides a strategy by which the degree of risk associated with each known parameter can be calculated and allocates resources in a manner that manages risk to an acceptable level.

Entities:  

Keywords:  Bayesian Monte Carlo simulation; ciprofloxacin and granulation; ciprofloxacin hydrochloride; qualitative risk assessment; quality-by-design (QbD); roller compaction

Mesh:

Substances:

Year:  2015        PMID: 26202064      PMCID: PMC4984889          DOI: 10.1208/s12249-015-0349-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  Effect of magnesium stearate on the content uniformity of active ingredient in pharmaceutical powder mixtures.

Authors:  Vidya Swaminathan; Dane O Kildsig
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

2.  Physical and lubrication properties of magnesium stearate.

Authors:  U I Leinonen; H U Jalonen; P A Vihervaara; E S Laine
Journal:  J Pharm Sci       Date:  1992-12       Impact factor: 3.534

3.  PDA survey of quality risk management practices in the pharmaceutical, devices, & biotechnology industries.

Authors:  Ruhi Ahmed; Harold Baseman; Jorge Ferreira; Thomas Genova; William Harclerode; Jeffery Hartman; Samuel Kim; Nanette Londeree; Michael Long; William Miele; Timothy Ramjit; Marlene Raschiatore; Charles Tomonto
Journal:  PDA J Pharm Sci Technol       Date:  2008 Jan-Feb

4.  A Bayesian approach to the ICH Q8 definition of design space.

Authors:  John J Peterson
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

5.  Assessment of the critical factors affecting the porosity of roller compacted ribbons and the feasibility of using NIR chemical imaging to evaluate the porosity distribution.

Authors:  Hanpin Lim; Vivek S Dave; Linda Kidder; E Neil Lewis; Raafat Fahmy; Stephen W Hoag
Journal:  Int J Pharm       Date:  2011-03-01       Impact factor: 5.875

6.  Quality-by-design III: application of near-infrared spectroscopy to monitor roller compaction in-process and product quality attributes of immediate release tablets.

Authors:  Ravikanth Kona; Raafat M Fahmy; Gregg Claycamp; James E Polli; Marilyn Martinez; Stephen W Hoag
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

7.  Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form.

Authors:  A Palamakula; Mohammad T H Nutan; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

8.  Quality by design I: Application of failure mode effect analysis (FMEA) and Plackett-Burman design of experiments in the identification of "main factors" in the formulation and process design space for roller-compacted ciprofloxacin hydrochloride immediate-release tablets.

Authors:  Raafat Fahmy; Ravikanth Kona; Ramesh Dandu; Walter Xie; Gregg Claycamp; Stephen W Hoag
Journal:  AAPS PharmSciTech       Date:  2012-09-20       Impact factor: 3.246

9.  The evaluation of fine-particle hydroxypropylcellulose as a roller compaction binder in pharmaceutical applications.

Authors:  G W Skinner; W W Harcum; P E Barnum; J H Guo
Journal:  Drug Dev Ind Pharm       Date:  1999-10       Impact factor: 3.225

10.  Physical mechanical and tablet formation properties of hydroxypropylcellulose: in pure form and in mixtures.

Authors:  Katharina M Picker-Freyer; Thomas Dürig
Journal:  AAPS PharmSciTech       Date:  2007-11-09       Impact factor: 3.246

View more
  2 in total

1.  Quality-by-design III: application of near-infrared spectroscopy to monitor roller compaction in-process and product quality attributes of immediate release tablets.

Authors:  Ravikanth Kona; Raafat M Fahmy; Gregg Claycamp; James E Polli; Marilyn Martinez; Stephen W Hoag
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

2.  Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin.

Authors:  Marilyn Martinez; Bipin Mistry; Viera Lukacova; Jim Polli; Stephen Hoag; Thomas Dowling; Ravikanth Kona; Raafat Fahmy
Journal:  AAPS J       Date:  2016-04-26       Impact factor: 4.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.